APA (7th ed.) Citation

H, T., ZJ, M., W, J., E, L., S, C., S, M., . . . M, K. (2025). Precision Medicine Proof-of-Concept Study of a TNF Inhibitor in FSGS and Treatment-Resistant Minimal Change Disease. Kidney360, 6(2), 284. https://doi.org/10.34067/KID.0000000635

Chicago Style (17th ed.) Citation

H, Trachtman, et al. "Precision Medicine Proof-of-Concept Study of a TNF Inhibitor in FSGS and Treatment-Resistant Minimal Change Disease." Kidney360 6, no. 2 (2025): 284. https://doi.org/10.34067/KID.0000000635.

MLA (9th ed.) Citation

H, Trachtman, et al. "Precision Medicine Proof-of-Concept Study of a TNF Inhibitor in FSGS and Treatment-Resistant Minimal Change Disease." Kidney360, vol. 6, no. 2, 2025, p. 284, https://doi.org/10.34067/KID.0000000635.